Delisting riskPopularity #4,595
MBAI · NASDAQ · Biotechnology

Check-Cap (MBAI)

Maintains legacy C-Scan assets while pursuing a merger with embodied-AI operator MBody.

$6.10
vs last close−0.28 (−4.39%)

Not reported.